Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women
This study has been completed.
Study NCT00952887   Information provided by Acceleron Pharma, Inc.

First Received on August 4, 2009.   Last Updated on March 22, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Muscular Atrophy
Additional conditions recognized in this trial
Atrophy
More general conditions related to this trial
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Pathological Conditions, Anatomical
Signs and Symptoms
Interventions listed in this trial
ACE-031
Placebo
Sponsors listed in this trial
Acceleron Pharma, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services